UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

SARS-CoV-2 Mpro inhibitors and activity-based probes for patient-sample imaging

Nature chemical biology, 2021-02, Vol.17 (2), p.222-228

2021

Volltextzugriff (PDF)

Protease targeted COVID-19 drug discovery and its challenges: Insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors

Bioorganic & medicinal chemistry, 2021-01, Vol.29, p.115860-115860, Article 115860

2021

Volltextzugriff (PDF)

Evaluation of green tea polyphenols as novel corona virus (SARS CoV-2) main protease (Mpro) inhibitors - an in silico docking and molecular dynamics simulation study

Journal of biomolecular structure & dynamics, 2021-08, Vol.39 (12), p.4362-4374

2021

Volltextzugriff (PDF)

In silico identification of potential inhibitors of key SARS-CoV-2 3CL hydrolase (Mpro) via molecular docking, MMGBSA predictive binding energy calculations, and molecular dynamics simulation

PloS one, 2020-07, Vol.15 (7), p.e0235030-e0235030

2020

Volltextzugriff (PDF)

Withanone and caffeic acid phenethyl ester are predicted to interact with main protease (Mpro) of SARS-CoV-2 and inhibit its activity

Journal of biomolecular structure & dynamics, 2021-07, Vol.39 (11), p.3842-3854

2021

Volltextzugriff (PDF)

Structural and Evolutionary Analysis Indicate That the SARS-CoV-2 Mpro Is a Challenging Target for Small-Molecule Inhibitor Design

International journal of molecular sciences, 2020-04, Vol.21 (9), p.3099

2020

Volltextzugriff (PDF)

Sequence-dependent cargo recognition by SNX-BARs mediates retromer-independent transport of CI-MPR

The Journal of cell biology, 2017-11, Vol.216 (11), p.3695-3712

2017

Volltextzugriff (PDF)

An automatic pipeline for the design of irreversible derivatives identifies a potent SARS-CoV-2 Mpro inhibitor

Cell chemical biology, 2021-12, Vol.28 (12), p.1795-1806.e5

2021

Volltextzugriff (PDF)

Mechanism of inhibition of SARS-CoV-2 Mpro by N3 peptidyl Michael acceptor explained by QM/MM simulations and design of new derivatives with tunable chemical reactivity

Chemical science (Cambridge), 2020-11, Vol.12 (4), p.1433-1444

2020

Volltextzugriff (PDF)

Benchmark of Popular Free Energy Approaches Revealing the Inhibitors Binding to SARS-CoV-2 Mpro

Journal of chemical information and modeling, 2021-05, Vol.61 (5), p.2302-2312

2021

Volltextzugriff (PDF)

In search of RdRp and Mpro inhibitors against SARS CoV-2: Molecular docking, molecular dynamic simulations and ADMET analysis

Journal of molecular structure, 2021-09, Vol.1239, p.130488-130488, Article 130488

2021

Volltextzugriff (PDF)

Targeting novel structural and functional features of coronavirus protease nsp5 (3CL pro , M pro ) in the age of COVID-19

Journal of general virology, 2021-03, Vol.102 (3)

2021

Volltextzugriff (PDF)

Benchmarking the Ability of Common Docking Programs to Correctly Reproduce and Score Binding Modes in SARS-CoV‑2 Protease Mpro

Journal of chemical information and modeling, 2021-06, Vol.61 (6), p.2957-2966

2021

Volltextzugriff (PDF)

Structure-Based Discovery of Novel Nonpeptide Inhibitors Targeting SARS-CoV‑2 Mpro

Journal of chemical information and modeling, 2021-08, Vol.61 (8), p.3917-3926

2021

Volltextzugriff (PDF)

Chemical-informatics approach to COVID-19 drug discovery: Exploration of important fragments and data mining based prediction of some hits from natural origins as main protease (Mpro) inhibitors

Journal of molecular structure, 2021-01, Vol.1224, p.129026-129026, Article 129026

2021

Volltextzugriff (PDF)

SARS-CoV-2 Mpro: A Potential Target for Peptidomimetics and Small-Molecule Inhibitors

Biomolecules (Basel, Switzerland), 2021-04, Vol.11 (4), p.607

2021

Volltextzugriff (PDF)

Impact of Early Pandemic Stage Mutations on Molecular Dynamics of SARS-CoV‑2 Mpro

Journal of chemical information and modeling, 2020-10, Vol.60 (10), p.5080-5102

2020

Volltextzugriff (PDF)

Advances in the Development of SARS-CoV-2 Mpro Inhibitors

Molecules (Basel, Switzerland), 2022-04, Vol.27 (8), p.2523

2022

Volltextzugriff (PDF)

Structural and Biochemical Analysis of the Dual Inhibition of MG-132 against SARS-CoV-2 Main Protease (Mpro/3CLpro) and Human Cathepsin-L

International journal of molecular sciences, 2021-11, Vol.22 (21), p.11779

2021

Volltextzugriff (PDF)

DNA-encoded chemistry technology yields expedient access to SARS-CoV-2 Mpro inhibitors

Proceedings of the National Academy of Sciences - PNAS, 2021-09, Vol.118 (36)

2021

Volltextzugriff (PDF)

Genetic Surveillance of SARS-CoV-2 Mpro Reveals High Sequence and Structural Conservation Prior to the Introduction of Protease Inhibitor Paxlovid

mBio, 2022-08, Vol.13 (4), p.e0086922-e0086922

2022

Volltextzugriff (PDF)

The SARS‐CoV‐2 main protease (Mpro): Structure, function, and emerging therapies for COVID‐19

MedComm (2020), 2022-09, Vol.3 (3), p.e151-n/a

2022

Volltextzugriff (PDF)

mProphet: automated data processing and statistical validation for large-scale SRM experiments

Nature methods, 2011-05, Vol.8 (5), p.430-435

2011

Volltextzugriff (PDF)

Identification of SARS-CoV-2 inhibitors targeting Mpro and PLpro using in-cell-protease assay

Communications biology, 2022-02, Vol.5 (1), p.169-169, Article 169

2022

Volltextzugriff (PDF)

In-Silico approach for identification of effective and stable inhibitors for COVID-19 main protease (Mpro) from flavonoid based phytochemical constituents of Calendula officinalis

Journal of biomolecular structure & dynamics, 2021-11, Vol.39 (16), p.6265-6280

2021

Volltextzugriff (PDF)

1 – 25 von 196.587

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(135.198)
Mit Volltextzugriff
(159.412)

Publikationsform

Artikel
(154.340)
Dissertationen
(21.197)
Buchkapitel
(9.329)
Tagungsberichte
(4.089)
magazinearticle
(3.413)
Reviews
(2.450)
Berichte
(706)
Bücher
(391)
Texte
(273)
Referenzeintrag
(193)
Datensätze
(114)
Newsletter-Artikel
(78)
Zeitungsartikel
(10)
Webseiten
(4)

9 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(186.317)
Japanisch
(13.775)
Französisch
(3.195)
Spanisch
(2.729)
Deutsch
(2.330)
Portugiesisch
(2.294)
Türkisch
(496)
Chinesisch
(486)
Italienisch
(419)
Rumänisch
(185)
Russisch
(166)
Bahasa Indonesia
(161)
Polnisch
(137)
Norwegisch
(121)
Tschechisch
(80)
Litauisch
(70)
Koreanisch
(68)
Serbian
(65)
Hindi
(61)
Latein
(58)

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(96.322)
Life Sciences & Biomedicine
(66.857)
Humans
(42.620)
Female
(24.598)
Male
(24.045)
Technology
(20.155)
Neurosciences & Neurology
(16.701)
Adult
(16.222)
Neurosciences
(16.081)
Magnetic Resonance Imaging
(15.111)
Social Sciences
(14.739)
Physical Sciences
(14.467)
Middle Aged
(12.794)
Radiology, Nuclear Medicine & Medical Imaging
(11.455)
Engineering
(11.440)
Neuroimaging
(10.698)
Aged
(9.441)
Medicine
(9.226)
Computer Science
(8.757)
Studies
(8.396)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(73.992)
Ingenta
(68.275)
MEDLINE
(50.386)
IngentaConnect Journals
(38.451)
Lippincott Journal Package
(35.186)
SpringerLink Journals - AutoHoldings
(26.336)
ProQuest Dissertations & Theses A&I
(21.186)
Wiley-Blackwell Journals
(18.564)
Elsevier ScienceDirect Journals Complete
(18.036)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(17.995)
Wiley Online Library
(13.710)
NUS Single-Journal Subscriptions
(12.654)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(12.257)
Business Source Ultimate
(9.808)
Ebook Central Perpetual and DDA
(8.919)
eBooks on EBSCOhost
(8.420)
Taylor & Francis Journals Auto-Holdings Collection
(7.415)
Jstor Complete Legacy
(7.103)
Taylor & Francis Online
(6.773)
Taylor & Francis
(6.385)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Neuroimage
(3.375)
Plos One
(2.905)
Journal Of Physics. Conference Series
(2.196)
Journal Of Physics: Conference Series
(2.030)
Ieee Pervasive Computing
(1.960)
Iop Conference Series. Earth And Environmental Science
(1.788)
Scientific Reports
(1.775)
Iop Conference Series: Earth And Environmental Science
(1.679)
Iop Conference Series. Materials Science And Engineering
(1.548)
Iop Conference Series: Materials Science And Engineering
(1.318)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

SARS-CoV-2 Mpro inhibitors and activity-based probes for patient-sample imaging

Protease targeted COVID-19 drug discovery and its challenges: Insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors

Evaluation of green tea polyphenols as novel corona virus (SARS CoV-2) main protease (Mpro) inhibitors - an in silico docking and molecular dynamics simulation study

In silico identification of potential inhibitors of key SARS-CoV-2 3CL hydrolase (Mpro) via molecular docking, MMGBSA predictive binding energy calculations, and molecular dynamics simulation

Withanone and caffeic acid phenethyl ester are predicted to interact with main protease (Mpro) of SARS-CoV-2 and inhibit its activity

Structural and Evolutionary Analysis Indicate That the SARS-CoV-2 Mpro Is a Challenging Target for Small-Molecule Inhibitor Design

Sequence-dependent cargo recognition by SNX-BARs mediates retromer-independent transport of CI-MPR

An automatic pipeline for the design of irreversible derivatives identifies a potent SARS-CoV-2 Mpro inhibitor

Mechanism of inhibition of SARS-CoV-2 Mpro by N3 peptidyl Michael acceptor explained by QM/MM simulations and design of new derivatives with tunable chemical reactivity

Benchmark of Popular Free Energy Approaches Revealing the Inhibitors Binding to SARS-CoV-2 Mpro

In search of RdRp and Mpro inhibitors against SARS CoV-2: Molecular docking, molecular dynamic simulations and ADMET analysis

Targeting novel structural and functional features of coronavirus protease nsp5 (3CL pro , M pro ) in the age of COVID-19

Benchmarking the Ability of Common Docking Programs to Correctly Reproduce and Score Binding Modes in SARS-CoV‑2 Protease Mpro

Structure-Based Discovery of Novel Nonpeptide Inhibitors Targeting SARS-CoV‑2 Mpro

Chemical-informatics approach to COVID-19 drug discovery: Exploration of important fragments and data mining based prediction of some hits from natural origins as main protease (Mpro) inhibitors

SARS-CoV-2 Mpro: A Potential Target for Peptidomimetics and Small-Molecule Inhibitors

Impact of Early Pandemic Stage Mutations on Molecular Dynamics of SARS-CoV‑2 Mpro

Advances in the Development of SARS-CoV-2 Mpro Inhibitors

Structural and Biochemical Analysis of the Dual Inhibition of MG-132 against SARS-CoV-2 Main Protease (Mpro/3CLpro) and Human Cathepsin-L

DNA-encoded chemistry technology yields expedient access to SARS-CoV-2 Mpro inhibitors

Genetic Surveillance of SARS-CoV-2 Mpro Reveals High Sequence and Structural Conservation Prior to the Introduction of Protease Inhibitor Paxlovid

The SARS‐CoV‐2 main protease (Mpro): Structure, function, and emerging therapies for COVID‐19

mProphet: automated data processing and statistical validation for large-scale SRM experiments

Identification of SARS-CoV-2 inhibitors targeting Mpro and PLpro using in-cell-protease assay

In-Silico approach for identification of effective and stable inhibitors for COVID-19 main protease (Mpro) from flavonoid based phytochemical constituents of Calendula officinalis

Suchergebnisse filtern